Nuclera raised €69M in a Series A round in Oct 2024. The company is based in Cambridge, UK. Investors in the round: Cambridge Innovation Capital, E Ink Holdings, Elevage Medical Technologies and 7 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
